Three different α2-adrenoceptor (α2-AR) subtypes have been described. The α2A-AR and α2C-AR subtypes are highly expressed in the human prefrontal cortex, where they modulate neurotransmission. However, due to the lack of subtype-selective ligands, the physiological relevance of both subtypes has not been fully resolved.
Aims:
In this context, the aim of the present study was to characterize the protein expression of both α2-AR subtypes, in different synaptic fractions of postmortem human prefrontal cortex.
Methods:
A subcellular fractionation of the samples was performed and the protein expression of α2A- and α2C-ARs was measured in presynaptic membranes and postsynaptic density fractions by Western blot.
Results:
The results revealed that the α2A-AR subtype is mainly located postsynaptically (95±3%) whereas the remaining 5±3% is in the presynapse. Conversely, the α2C-AR subtype showed a similar distribution between pre- and postsynaptic membranes, with a slightly higher percentage present in the presynapse (60±2% vs. 40±2%).
Conclusions:
These findings could explain some contradictory effects reported for α2-AR agonists and antagonists in the human prefrontal cortex. Furthermore, the present data could contribute to elucidating the therapeutic potential of selectively targeting α2A- or α2C-AR subtypes.
AndenNGrabowskaM (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol39: 275–282.
2.
AokiCGoCGVenkatesanCet al. (1994) Perikaryal and synaptic localization of α2A-adrenergic receptor-like immunoreactivity. Brain Res650: 181–204.
3.
AokiCVenkatesanCGoCGet al. (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex8: 269–277.
4.
ArnstenAFWangM (2016) Targeting prefrontal cortical systems for drug development: Potential therapies for cognitive disorders. Annu Rev Pharmacol Toxicol56: 339–360.
5.
BeaniLBianchiCGiacomelliAet al. (1978) Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol48: 179–193.
6.
BermejoMKMilenkovicMSalahpourAet al. (2014) Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient. J Vis Exp91: e51896.
7.
BjörklundMSirviöJSallinenJet al. (1999) Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Neuroscience88: 1187–1198.
8.
BuchelerMMHadamekKHeinL (2002) Two α2-adrenergic receptor subtypes, α2A and α2C, inhibit transmitter release in the brain of gene-targeted mice. Neuroscience109: 819–826.
9.
CalladoLFStamfordJA (1999) α2A- But not α2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: Voltammetric data. Eur J Pharmacol366: 35–39.
10.
ErdozainAMRubioMValdizanEMet al. (2015) The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects. Addict Biol20: 773–783.
11.
EstebanSLladoJGarcía-SevillaJA (1996) α2-Autoreceptors and α2- heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: An investigation into the α2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol353: 391–399.
12.
Fernández-PastorBMeanaJJ (2002) In vivo tonic modulation of the noradrenaline release in the rat cortex by locus coeruleus somatodendritic alpha(2) adrenoceptors. Eur J Pharmacol442: 225–229.
13.
GilsbachRRöserCBeetzNet al. (2009) Genetic dissection of α2-adrenoceptor functions in adrenergic versus nonadrenergic cells. Mol Pharmacol75: 1160–1170.
14.
GrijalbaBCalladoLFMeanaJJet al. (1996) α2-Adrenoceptor subtypes in the human brain: A pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol310: 83–93.
15.
HahnC-GBanerjeeAMacdonaldMLet al. (2009) The post-synaptic density of human postmortem brain tissues: An experimental study paradigm for neuropsychiatric illnesses. PloS One4: e5251.
16.
HeinLKobilkaBK (1995) Adrenergic receptor signal transduction and regulation. Neuropharmacology34: 357–366.
17.
IhalainenJATanilaH (2002) In vivo regulation of dopamine and noradrenaline release by α2A-adrenoceptors in the mouse prefrontal cortex. Eur J Neurosci15: 1789–1794.
18.
JäkäläPRiekkinenMSirviöJet al. (1999) Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology20: 460–470.
19.
KobilkaBKMatsuiHKobilkaTSet al. (1987) Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. Science238: 650–656.
20.
LeeARosinDLVan BockstaeleEJ (1998a) Ultrastructural evidence for prominent postsynaptic localization of α2C-adrenergic receptors in catecholaminergic dendrites in the rat nucleus locus coeruleus. J Comp Neurol394: 218–229.
21.
LeeAWissekerkeAERosinDLet al. (1998b) Localization of α2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience84: 1085–1096.
22.
Le PenGMoreauJ-L (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: Reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology27: 1:11.
23.
LomasneyJWLorenzWAllenLFet al. (1990) Expansion of the α2-adrenergic receptor family: Cloning and characterization of a human α2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci USA87: 5094–5098.
24.
MenarguesAObachRGarcía-SevillaA (1990) Modulation by antidepressant drugs of CNS postsynaptic α2-adrenoceptors mediating mydriasis in the rat. Naunyn Schmiedebergs Arch Pharmacol341: 101–107.
25.
MilnerTALeeAAicherSAet al. (1998) Hippocampal α2A-adrenergic receptors are located predominantly presynaptically but are also found postsynaptically and in selective astrocytes. J Comp Neurol395: 310–327.
26.
NumazawaRYoshiokaMMatsumotoMet al. (1995) Pharmacological characterization of α2-adrenoceptor regulated serotonin release in the rat hippocampus. Neurosci Lett192: 161–164.
27.
OranjeBGlenthøjBY (2013) Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication. Schizophr Bull39: 684–691.
28.
OrdwayGAJaconettaSMHalarisAE (1993) Characterization of subtypes of alpha-2 adrenoceptors in the human brain. J Pharmacol Exp Ther264: 967–976.
29.
OzcetinACevreliBUzbayT (2016) Investigation of the role of alpha-2 adrenergic receptors on prepulse inhibition of acoustic startle reflex in rats. Synapse70: 501–507.
30.
RamosBPStarkDVerduzcoLet al. (2006) α2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn Mem13: 770–776.
31.
RaymondJRHnatowichMLefkowitzRJet al. (1990) Adrenergic receptors. Models for regulation of signal transduction processes. Hypertension15: 119–131.
32.
ReganJWKobilkaTSYang-FengTLet al. (1988) Cloning and expression of a human kidney cDNA for an α2-adrenergic receptor subtype. Proc Natl Acad Sci USA85: 6301–6305.
33.
SallinenJHaapalinnaAViitamaaTet al. (1998) Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci18: 3035–3042.
34.
SastreMGarcía-SevillaJA (1994) α2-Adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: The agonist guanoxabenz does not discriminate different forms of the predominant α2A subtype. J Neurochem63: 1077–1085.
35.
TóthAPetykóZGálosiRet al. (2017) Neuronal coding of auditory sensorimotor gating in medial prefrontal cortex. Behav Brain Res326: 200–208.
36.
TrendelenburgAUKlebroffWHeiLet al. (2001) A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol364: 117–130.
37.
UysMMShahidMHarveyBH (2017) Therapeutic potential of selectively targeting the α2C-adrenoceptor in cognition, depression, and schizophrenia-New developments and future perspective. Frontiers in Psychiatry8: 144.
38.
WangMRamosBPPaspalasCDet al. (2007) α2A-Adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell129: 397–410.
39.
YiFLiuSSLuoFet al. (2013) Signaling mechanism underlying α2A-adrenergic suppression of excitatory synaptic transmission in the medial prefrontal cortex of rats. Eur J Neurosci38: 2364–2373.
40.
ZhangWKlimekVFarleyJet al. (1999) α2C Adrenoceptors inhibit adenylyl cyclase in mouse striatum: Potential activation by dopamine. J Pharmacol Exp Ther289: 1286–1292.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
